Clinical Trial Update: Qsymia as an Adjunct to Surgical Therapy in the Superobese [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Qsymia as an adjunct to surgical therapy in the superobese; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Weight Loss Disorders

Drugs mentioned

• Qsymia (phentermine/topiramate)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Obesity, Metabolic Surgery | Phase 2 | Status: COMPLETED | Results posted: 2019-09-04